Leslie Wardwell-Scott, Ph.D., has served as Vice President, Head of Corporate Development and Strategic Integration since 2015. Prior to joining Evelo, Leslie was an Entrepreneurial Fellow at Flagship Pioneering and the Senior Business Development Fellow in Harvard University’s Office of Technology Development. Leslie completed her Ph.D. at Harvard Medical School, where she studied the complex interactions between microbes and the immune system in the small intestine.
Chun Zhang, Ph.D., has served as Chief Technical Operations and Quality Officer since 2017. Prior to joining Evelo, Chun was Vice President and Head of Bioprocess Development at Shire. Chun has also served as Head of Cell Culture Development at Bayer Healthcare LLC, as well as Head of Technical Operations at WuXi AppTec, Inc. Chun received his Ph.D. in Chemical Engineering from University of Minnesota and B.S. in Chemical Engineering from Zhejiang University.
Jonathan Zung, Ph.D., has served as Chief Development Officer since January 2021. Prior to joining Evelo, Jonathan was President of Sponsor and CRO Programs at WCG Clinical. Prior to WCG Clinical, he served as the Group President of Clinical Development and Commercialization Services at Covance Drug Development, where he led a global organization of over 8,000 employees in 60 countries spanning all phases of development (Phase 1-4), along with global market access services. Jonathan has also held leadership roles of increasing responsibility at UCB, Bristol Myers Squibb, and Pfizer. Jonathan received his Ph.D. in analytical chemistry from Emory University and a B.S. in chemistry from the Florida Institute of Technology.